Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
2.11 EUR | +0.48% | +3.94% | -40.65% |
May. 13 | AB Science: European patent granted for masitinib | CF |
May. 03 | AB Science: upbeat after legal success | CF |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-40.65% | 116M | |
+13.46% | 74.45B | |
+11.35% | 9.18B | |
+60.16% | 5.03B | |
-12.85% | 5.02B | |
+1.60% | 3.82B | |
-19.20% | 2.41B | |
+18.73% | 2.39B | |
-27.46% | 2.27B | |
+24.62% | 2.26B |
- Stock Market
- Equities
- AB Stock
- News AB Science
- France's AB Science Secures Canadian Patent for Rare Neurological Disease Drug